6Steele MA, Burk RF, Desprez RM. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest, 1991,99 : 465-471.
7Roy B, Chowdhury A, Kundu S, et al. Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1" null" mutation J Gastroenterol Hepatol, 2001,16 : 1033-1037.
8Sun F, Chen Y, Xiang Y, et al. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis. Int J Tuberc Lung Dis, 2008,12: 994-1002.
9Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11 : 272-276.
10Ohno M, Yamaguchi I, Yamamoto I, et al. Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. Int J Tuberc Lung Dis, 2000, 4 : 256 -261.
